Cilostazol
Noclaud, which contains the active ingredient cilostazol, belongs to a group of medicines called phosphodiesterase type 3 inhibitors. It has various effects, including the dilation of certain blood vessels and the reduction of the activity of blood clotting (aggregation) of certain blood cells, called platelets, within blood vessels.
Noclaud has been prescribed to treat "intermittent claudication". Intermittent claudication is a type of cramp-like pain in the lower limbs that occurs during walking and is caused by insufficient blood flow to the legs. Noclaud increases the distance that the patient can walk without experiencing pain by improving blood circulation in the lower limbs.
Cilostazol is recommended only for patients for whom lifestyle modifications (including quitting smoking and increasing exercise intensity) and other appropriate interventions have not sufficiently alleviated symptoms. It is essential that the patient continues to implement lifestyle modifications during cilostazol treatment.
Before starting to use Noclaud, you should discuss it with your doctor or pharmacist
During treatment with Noclaud
Noclaud is not intended for children.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
In particular, you should inform your doctor about taking certain medicines that are usually used to treat pain and/or inflammation of muscles or joints, as well as medicines that reduce blood clotting. These include:
In the case of using such medicines together with Noclaud, the doctor may perform certain routine blood tests.
Some medicines used at the same time may interfere with the action of Noclaud. They may enhance the side effects of Noclaud or reduce its effectiveness. Noclaud may similarly affect other medicines. Before starting to use Noclaud, you should inform your doctor about taking:
In case of doubt whether the above applies to the medicines you are taking, you should consult your doctor or pharmacist.
Before starting to use Noclaud, you should inform your doctor if you are taking medicines for high blood pressure, as Noclaud may cause additional blood pressure-lowering effects. If excessive blood pressure lowering occurs, it may lead to rapid heart rate. These medicines include:
It is possible that the concurrent use of the above medicines and Noclaud will still be acceptable, and the doctor will be able to decide what treatment is appropriate for the patient.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, you should consult your doctor or pharmacist before using this medicine.
Noclaud MUST NOTbe used during pregnancy.
IT IS NOT RECOMMENDEDto use Noclaud in breastfeeding mothers.
Noclaud may cause dizziness. If dizziness occurs after taking Noclaud, DO NOTdrive vehicles, do not use any tools, or operate any machines. You should inform your doctor or pharmacist.
This medicine should always be taken as directed by your doctor or pharmacist. If you are unsure, you should consult your doctor or pharmacist.
Some benefits of using Noclaud may be noticeable after 4-12 weeks of treatment.
The doctor will assess the effectiveness after 3 months of treatment and may recommend discontinuing cilostazol treatment if the therapy is not effective enough.
Noclaud is not intended for children.
If, for any reason, you have taken more Noclaud tablets than you should, you may experience objective and subjective symptoms such as severe headaches, diarrhea, low blood pressure, and irregular heart rhythm.
In case of taking a higher dose than prescribed, you should immediately contact your doctor or local hospital. Remember to take the packaging with you so that it is clear what medicine has been taken.
There is no reason to worry if you miss a dose. You should wait and take the next dose at the right time, and then take the medicine as directed. DO NOTtake a double dose to make up for the missed tablet.
If you stop using Noclaud, the pain in your lower limbs may return or worsen. Therefore, you should only stop using Noclaud if you experience side effects that require urgent medical attention (see section 4) or on the advice of your doctor.
If you have any further doubts about using this medicine, you should consult your doctor or pharmacist.
Like all medicines, Noclaud can cause side effects, although not everybody gets them.
If you experience any of the following side effects, you may need urgent medical attention. You should immediately stop using Noclaud and contact your doctor or go to the nearest hospital.
You should also immediately inform your doctor if you experience fever or sore throat.
It may be necessary to perform certain blood tests, and your doctor will decide on further treatment.
Very common side effects(may affect more than 1 in 10 people)
Common side effects(may affect up to 1 in 10 people)
Uncommon side effects(may affect up to 1 in 100 people)
In people with diabetes, there may be a higher risk of bleeding into the eye.
Rare side effects(may affect up to 1 in 1000 people)
The following side effects have been reported during the use of cilostazol, but their frequency is unknown(the frequency cannot be estimated from the available data);
If any of the side effects get worse, you should tell your doctor or pharmacist.
If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help provide more information on the safety of this medicine.
There are no special precautions for storage.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of the month.
Do not use this medicine if you notice visible signs of deterioration (e.g., discoloration).
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Odorless or almost odorless, white or almost white, round, flat tablets with beveled edges. The tablets have a stylized letter E and the number 602 embossed on one side, with no markings on the other side.
The available packages are 28 or 56 tablets in PVC/PVDC/Aluminum blisters in a cardboard box.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Egis Gyógyszergyár Zrt.
Keresztúri út 30-38.
1106 Budapest
Hungary
Egis Gyógyszergyár Zrt.
Bökényföldi út 118-120.
1165 Budapest
Hungary
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Laboratorium Galenowe Olsztyn Sp. z o.o.
ul. Spółdzielcza 25A
11-001 Dywity
CEFEA Sp. z o.o. Sp. komandytowa
ul. Działkowa 56
02-234 Warsaw
Pharma Innovations Sp. z o.o.
ul. Jagiellońska 76
03-301 Warsaw
IVA Pharm Sp. z o.o.
ul. Drawska 14/1
02-202 Warsaw
CANPOLAND SPÓŁKA AKCYJNA
ul. Beskidzka 190
91-610 Łódź
Hungary Noclaud 100 mg tablet
Czech Republic Noclaud
Latvia Sollazon 100 mg tablets
Lithuania Sollazon 100 mg tablets
Poland Noclaud
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.